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Abstract: Antibiotic resistance still remains a major global public health problem and the dispensing
of antibiotics without a prescription at community pharmacies is an important driver of this.
MEDLINE, Pubmed and EMBASE databases were used to search and identify studies reporting the
dispensing of non-prescribed antibiotics in community pharmacies or drugstores that sell drugs for
human use, by applying pharmacy interviews/questionnaires methods and/or simulated patient
methods. Of the 4683 studies retrieved, 85 were included, of which 59 (69.4%) were published in
low-and middle-income countries. Most of the papers (83.3%) presented a percentage of antibiotic
dispensing without a prescription above 60.0%. Sixty-one studies evaluated the active substance
and the most sold antibiotics without a prescription were amoxicillin (86.9%), azithromycin (39.3%),
ciprofloxacin (39.3%), and amoxicillin-clavulanic acid (39.3%). Among the 65 articles referencing
the diseases/symptoms, this practice was shown to be mostly associated with respiratory system
problems (100.0%), diarrhea (40.0%), and Urinary Tract Infections (30.8%). In sum, antibiotics are
frequently dispensed without a prescription in many countries and can thus have an important
impact on the development of resistance at a global level. Our results indicate the high need to
implement educational and/or regulatory/administrative strategies in most countries, aiming to
reduce this practice.
Keywords: antibiotics; non-prescription antibiotic dispensing; pharmacy practice; self-medication
1. Introduction
Antibiotic resistance remains one of the major global public health problems, due to its impact on
morbidity, mortality, and healthcare costs. Despite the alerts from international organizations [1–3],
the trend towards antibiotic consumption is continuing to increase in some countries, especially in
low-and middle-income countries [4]. In recent years, some high-income countries have manged
to decrease the consumption of antibiotics, suggesting that the educational/regulatory strategies
developed over the past few years are having some impact on slowing down the consumption [5]
projections of global antibiotic consumption in 2030, assuming no policy changes, by up to 200% [4].
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Although many factors can explain these increases in antibiotic use and resistance, the dispensing
of antibiotics without prescription in community pharmacies is still one of the most important
factors [6,7]. It is estimated that over-the-counter dispensing may account for half of the antibiotic
sales worldwide [8], even though in North America, Northern Europe, and Australia this pratically
doe not exist [7]. This self-medication is associated with an inadequate use of antibiotics, inadequate
dosages, and duration of treatments that increase the risk of resistant bacteria selection [9].
To assess the magnitude of dispensing antibiotics without prescription, several methods have
been proposed, mainly in simulated patients and pharmacy interviews, each with its advantages and
limitations. On the one hand, simulated patients (an individual visiting a pharmacy simulating specific
symptoms and requiring an antibiotic) avoid the Hawthorne effect (changes in the behavior of the
studied pharmacists because they feel observed), and make it impossible to speak about complacency,
since these patients are generally unknown to the pharmacist [10]. In contrast, pharmacy interviews
allow a qualitative analysis and the possibility of introducing open questions, thus displaying a greater
Hawthorne effect and an evaluation of antibiotics dispensing due to complacency. Therefore, it seems
that both methods can provide complementary information.
This systematic review aims to identify and compare the frequency of dispensing antibiotics
without a prescription in the community pharmacies or drugstores that sell drugs for human use,
by using two different methods, pharmacy interviews/questionnaires and simulated patients.
2. Results
2.1. Search Results
The chosen search strategy identified a total of 4871 articles in MEDLINE Pubmed and Embase
databases, being that 188 articles were duplicated. After screening for title and abstract, 188 articles
potentially met the inclusion criteria and were selected for a reading of the complete text. Following an
in-depth reading, a total of 85 papers were finally included in this systematic review (Figure 1).
2.2. Quality Assessment
All the studies included in the systematic review complied with most of the questions in the AXIS
tool (Table 1). A high proportion of articles (64/85) fulfilled almost all of the criteria and were thus
regarded as displaying a high methodological quality and a low susceptibility to bias. Nineteen articles
failed to comply with four to six of the exploratory questions and were considered to have a medium
level of methodological quality. Two of the remaining articles failed to comply with more than
6 exploratory questions and were classified as having a low level of methodological quality.
2.3. Characteristics of the Studies Selected
A description of the general characteristics of the 85 included studies is presented in Table 1.
Among the included studies, 51 were conducted in Asia, 17 in Africa (including Egypt), 14 in
Europe (including Turkey), 2 in South America, and 1 in North America.
Regarding the study design, almost all of the included papers were cross-sectional studies
(72 of 85), 7 were prospective studies, 3 were cross-sectional prospective studies, 1 was a qualitative
exploratory study, 1 was a quantitative study, and 1 was an interventional study.
Of the total of 85 studies included in this review, 49 used the simulated patient method (Table 2)
as a data collection method and 33 used the pharmacy interviews/questionnaires method (Table 3).
Three of the studies included in the review used both methods.
Antibiotics 2020, 9, 786 3 of 49
Antibiotics 2020, 9, x FOR PEER REVIEW 3 of 45 
 
Figure 1. Study selection flowchart. 
2.4. Study Outcomes—Articles that Use the Simulated Patient Method 
Table 2 summarizes the extent of antibiotic dispensation without prescription and additional 
outcomes of the included articles that use the simulated patient method. 
2.4.1. Frequency of Antibiotic Dispensation without a Prescription 
Among the 52 articles that used a simulated patient method, 6 of them did not explicitly mention 
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justified by the fact that they present data related to the dispensing of antibiotics, without mentioning
the presence of a prescription anywhere in the article.
The frequency of antibiotic dispensation without a prescription is presented to (i) the total number
of pharmacies/drugstores/medicine retail outlets visited (40 articles); (ii) total number of visits made
(9 articles); (iii) total number of interactions (2 articles); and finally about (iv) the total number of drugs
dispensed (1 article).
Among the 40 articles that were presented, the dispensation of antibiotics to the total number of
pharmacies/drug stores/medicine retail outlets, the percentage of dispensation without a prescription of
these establishments, varied from 8.0% to 100.0%. About 25 articles made a percentages of dispensation
without a prescription above 60.0%.
Of the 9 articles that presented the percentage of dispensation without a prescription regarding
the total number of visits made, the percentage ranged from 5.0% to 87.6% of visits, resulting in an
antibiotic being dispensed without a prescription.
The two articles that presented the percentage of dismissal without a prescription in relation to
the total number of interactions varied from 4.0% to about 59.3%. Finally, only the article by Ibrahim
M.I.B. et al. [13] presented the percentage of dispensation without a prescription concerning the total
number of medicines dispensed, and obtained a value of 43.2%.
Those by Al-Tannir M. et al. [17], held in Saudi Arabia, and Marković-Peković V et al. [18],
held in Republic of Srpska and Herzegovina, compared the frequency of dispensing antibiotics without
prescription in two different years, 2011 and 2018 and 2010 and 2015, respectively. In both articles, it is
possible to observe a decrease in the frequency of dispensing antibiotics without a prescription from
the past to the most recent year (Al-Tannir M. et al. [17] (2011: 77.6%; 2018: 12.5%); Marković-Peković
V et al. [18] (2010: 58.0%; 2015: 18.5%)).
The highest percentages of antibiotic dispensation without a prescription associated with the
simulated patient method corresponded to studies carried out in Asian countries. However, the lowest
percentage of antibiotic dispensation without a prescription was recorded in a study conducted in
India [19].
Three articles conducted in Tanzania and Thailand [20–22] presented the percentage of antibiotic
dispensing without a prescription related to class I, legally authorized to dispense antibiotics without
prescription and class II that only sell them with a medical prescription. Two [20,22] of these articles
presented the percentage related to the two pharmacy classes, while 1 article [21] only presented the
percentage related to class I pharmacies. By comparing the percentages presented linked to both types
of pharmacy, it is possible to verify that a higher percentage is related to the type II pharmacies in the
two articles presented.
Additionally, the article by Minzi O et al. [23], held in Tanzania, also presents the percentage
of antibiotic dispensation without a prescription related to the accredited drug dispensing outlets
(ADDO) and the duka la dowa baridi (DLDB) also know as class II shops. According to the regulations
in Tanzania, DLDB are not authorised to sell prescription drugs, such as antibiotics. In contrast, ADDO
have been developed to improve the availability of medicines and are authorised to sell a limited
range of prescription medicines, among which are a restricted number of antibiotics. [23] In this article,
the authors reported a higher percentage related to ADDO, when compared to DLDB.
2.4.2. Name/Class of Antibiotics Most Often Dispensed without a Prescription
There were several antibiotics dispensed without a prescription. The antibiotics most commonly
mentioned in the included articles were amoxicillin (40 articles), azithromycin (24 articles), ciprofloxacin
(24 articles), and amoxicillin-clavulanic acid (21 articles).
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2.4.3. Types of Disease/Symptoms Most Commonly Associated with Dispensation without
a Prescription
The most used diseases/symptoms in the simulated patient methodology were diarrhea (23 articles),
urinary tract infections (UTI) (12 articles), upper respiratory tract infections (URTI) (11 articles),
sore throat (11 articles), common cold (6 articles), and bronchitis (6 articles). Others included
cough (5 articles), fever (5 articles), sinusitis (3 articles), otitis media (3 articles), rhinitis (3 articles),
and gastroenteritis (2 articles).
2.4.4. Level of Insistence by Patients
Of the 52 articles included in the systematic review, 21 used different levels of demand to obtain
antibiotics. Of these, 15 studies applied 3 levels of demand, 4 studies used 2 levels and, finally, 2 studies
presented 4 levels.
From the results obtained, it was possible to verify that most of the articles that presented 3 levels
of demand indicated that the majority of antibiotics were obtained at level 1, meaning they were only
obtained when something was asked for to alleviate the symptoms (6 articles).
In contrast, of the 4 articles that used 2 levels of demand, most indicated that antibiotics were
obtained according to level 2, that is when asking for a stronger medication or, more specifically,
an antimicrobial.
Of the 2 articles that used 4 levels of demand, only 1 presented information about the level at
which the highest amount of antibiotics was obtained, namely level 4, corresponding to the specific
request of the amoxicillin antibiotic.
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Table 1. Characteristics of the selected studies.





Abubakar U. et al. [24] 2020 Nigeria Cross-sectionalprospective study Pharmacy interviews/questionnaires High 7
Abubakar U. [25] 2020 Nigeria Cross-sectional study Pharmacy interviews/questionnaires High 6, 7, 13
Al-Tannir M. et al. [17] 2020 Saudi Arabia Cross-sectional study Simulated patient method High 7, 12, 14
Badro D.A. et al. [26] 2020 Lebanon Cross-sectional study Pharmacy interviews/questionnaires High 3, 7, 14
Bahta M. et al. [27] 2020 Eritrea Cross-sectional study Simulated patient method High 7, 13, 14
Chen J. et al. [28] 2020 China Cross-sectional study Simulated patient method High 6, 7, 14
Gajdács M. et al. [29] 2020 Hungary Cross-sectional study Pharmacy interviews/questionnaires High 3, 7, 14
Halboup A. et al. [30] 2020 Yemen Cross-sectional study Simulated patient method High 14
Shi L. et al. [31] 2020 China Cross-sectional study Simulated patient method High 6, 7, 14
Wang X. et al. [32] 2020 China Cross-sectional study Simulated patient method High 12, 14
Abdelaziz AI et al. [33] 2019 Egypt Cross-sectional study Simulated patient method High 14
Alrasheedy AA. et al. [34] 2019 Saudi Arabia Cross-sectional study Simulated patient method andpharmacy interviews/qestionnaires Medium 6, 7, 12, 14
Chang J. et al. [7] 2019 China Cross-sectional study Simulated patient method High 6, 7, 14
Damisie G et al. [35] 2019 Ethiopia Cross-sectional study Simulated patient method Medium 3, 7, 10, 14
Hallit S et al. [36] 2019 Lebanon Cross-sectional study Pharmacy interviews/questionnaires High 7, 13
Koji EM et al. [37] 2019 Ethiopia Cross-sectionalprospective study Simulated patient method High 7, 14
Mengistu G et al. [11] 2019 Ethiopia Cross-sectional study Simulated patient method andpharmacy interviews/questionnaires High 7, 14
Nafade V. et al. [19] 2019 India Cross-sectional study Simulated patient method High 7, 14
Zawahir S et al. [38] 2019 Sri Lanka Cross-sectional study Simulated patient method High 7, 14
Zawahir S. et al. [39] 2019 Sri Lanka Cross-sectional study Pharmacy interviews/questionnaires High 14
Ajie A.A.D. et al. [40] 2018 Indonesia Cross-sectional study Pharmacy interviews/questionnaires High 18
Alhomoud F et al. [41] 2018 Saudi Arabia Qualitative exploratorystudy Pharmacy interviews/questionnaires Medium 6, 7, 13, 14
Awosan KJ et al. [42] 2018 Nigeria Cross-sectional study Pharmacy interviews/questionnaires High 13, 14
Erku D.A. et al. [43] 2018 Ethiopia Cross-sectional study Simulated patient method High 3, 7, 14
Horumpende PG et al. [20] 2018 Tanzania Cross-sectional study Simulated patient method High 7, 14
Ibrahim IR et al. [12] 2018 Iraq Cross-sectional study Simulated patient method High 6, 7, 14
Mohamed Ibrahim M.I. et al. [44] 2018 Qatar Cross-sectional study Simulated patient method High 7, 14
Paes M.R. et al. [45] 2018 India Cross-sectional study Pharmacy interviews/questionnaires Medium 3, 7, 10, 11, 12, 14
Rehman IU et al. [46] 2018 Pakistan Cross-sectional study Pharmacy interviews/questionnaires Medium 3, 7, 13, 14
Sarwar M.R. et al. [47] 2018 Pakistan Cross-sectional study Pharmacy interviews/questionnaires High 7, 14
Zapata-Cachafeiro M et al. [48] 2018 Spain Cross-sectional study Simulated patient method High 7, 14
Zawahir S et al. [49] 2018 Sri Lanka Cross-sectional study Simulated patient method High 14
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Ansari M. [50] 2017 Nepal Cross-sectionalprospective study Pharmacy interviews/questionnaires High 7, 14
Barker A.K. et al. [51] 2017 India Cross-sectional study Pharmacy interviews/questionnaires High 7, 14
Chang J. et al. [52] 2017 China Cross-sectional study Simulated patient method High 7, 14
Jaisue S. et al. [21] 2017 Thailand Cross-sectional study Simulated patient method Medium 3, 7, 10, 14, 18
Mansour O. et al. [53] 2017 Syria Cross-sectional study Pharmacy interviews/questionnaires High 7, 13
Marković-Peković V et al. [18] 2017 Republic of Srpska andHerzegovina Cross-sectional study Simulated patient method High 7, 14, 18
Okuyan B. et al. [54] 2017 Turkey Cross-sectional study Simulated patient method High 7, 14, 18
Abegaz T.M. et al. [14] 2016 Ethiopia Cross-sectional study Simulated patient method High 6, 7, 14
Abood EA et al. [55] 2016 Yemen Cross-sectional study Pharmacy interviews/questionnaires High 3, 7, 14
Erku D.A. [56] 2016 Ethiopia Cross-sectional study Pharmacy interviews/questionnaires High 7, 14
Guinovart MC et al. [57] 2016 Spain Prospective study Simulated patient method Medium 3, 7, 10, 14, 18, 20
Ibrahim M.I.B.M. et al. [13] 2016 Qatar Cross-sectional study Simulated patient method High 7, 14
Kalungia AC et al. [58] 2016 Zambia Descriptivecross-sectional study Pharmacy interviews/questionnaires High 7, 14
Khan M.U. et al. [59] 2016 Malaysia Cross-sectional study Pharmacy interviews/questionnaires High 7, 13, 14
Nawab A. et al. [60] 2016 Pakistan Cross-sectional study Pharmacy interviews/questionnaires Medium 6, 7, 10, 12, 14, 18
Satyanarayana S. et al. [61] 2016 India Cross-sectional study Simulated patient method High 6, 7, 14
Almaaytah A et al. [62] 2015 Jordan Prospective study Simulated patient method Medium 7, 10, 14, 18
Bahnassi A. [63] 2015 Syria Cross-sectional study Pharmacy interviews/questionnaires High 7, 10, 18
Dorj G. et al. [64] 2015 Mongolia Cross-sectional study Pharmacy interviews/questionnaires High 7, 14
Shet A et al. [65] 2015 India Cross-sectional study Simulated patient method High 7, 14
Shreya Svitlana A. et al. [66] 2015 India Cross-sectional study Pharmacy interviews/questionnaires Low 6, 7, 9, 10, 11, 12,14, 18, 20
Alabid A.H.M.A. et al. [67] 2014 Malaysia Cross-sectional study Simulated patient method High 7, 14
Bahnassi A. [68] 2014 Saudi Arabia Cross-sectional study Pharmacy interviews/questionnaires High 7, 14
Farah R et al. [69] 2014 Lebanon Cross-sectional study Pharmacy interviews/questionnaires High 7, 14, 20
Gastelurrutia M.A. et al. [70] 2014 Spain Prospective study Pharmacy interviews/questionnaires Medium 3, 7, 10, 11, 14
Sabry NA et al. [71] 2014 Egypt Cross-sectional study Pharmacy interviews/questionnaires High 7
Zapata-Cachafeiro M. et al. [72] 2014 Spain Cross-sectional study Pharmacy interviews/questionnaires High 7, 9, 14
Abasaeed AE et al. [73] 2013 United Arab Emirates Cross-sectional study Pharmacy interviews/questionnaires High 7, 14
Malik M. et al. [15] 2013 Pakistan Cross-sectional study Simulated patient method High 3, 7, 18
Minzi O et al. [23] 2013 Tanzania Cross-sectional study Simulated patient method High 7, 9, 14
Marković-Peković V et al. al. [74] 2012 Republic of Srpska andHerzegovina Cross-sectional study Simulated patient method Medium 3, 7, 10, 14, 20
Rathnakar U.P. et al. [75] 2012 India Prospective study Simulated patient method High 7, 14, 18
Simó S et al. [76] 2012 Spain Prospective study Simulated patient method Medium 7, 12, 14, 20
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Al-Faham Z et al. [77] 2011 Syria Cross-sectional study Simulated patient method High 7, 10, 20
Al-Mohamadi A et al. [78] 2011 Saudi Arabia Cross-sectional study Simulated patient method Medium 7, 9, 14, 18, 20
Puspitasari HP et al. [79] 2011 Indonesia Cross-sectional study Simulated patient method High 7, 14
Hadi U et al. [80] 2010 Indonesia Cross-sectional study Simulated patient method High 7, 14
Llor C et al. [81] 2010 Spain Prospective study Simulated patient method Medium 3, 7, 14, 20
Plachouras D et al. [82] 2010 Greece Quantitative study Simulated patient method Medium 6, 7, 14, 18, 20
Saengcharoen W. et al. [22] 2010 Thailand Cross-sectional study Simulated patient method High 7, 14
Llor C et al. [83] 2009 Spain Prospective study Simulated patient method Medium 3, 7, 14, 20
Rauber C. et al. [84] 2009 Brazil Cross-sectional study Pharmacy interviews/questionnaires High 7, 9, 14
Viberg N et al. [85] 2009 Tanzania Cross-sectional study Simulated patient method High 7, 14, 18
Nyazema N et al. [86] 2007 Zimbabwean Cross-sectional study Simulated patient method andPharmacy interviews/questionnaires High 7, 13, 14
Caamaño F et al. [87] 2005 Spain Cross-sectional study Pharmacy interviews/questionnaires High 7, 14, 20
Volpato DE et al. [88] 2005 Brazil Cross-sectional study Simulated patient method Medium 7, 9, 10, 20
Caamano Isorna F. et al. [89] 2004 Spain Cross-sectional study Pharmacy interviews/questionnaires High 7, 20
Larson E et al. [90] 2004 United States of America Cross-sectional study Simulated patient method Medium 7, 14, 17, 18, 20
Chalker J et al. [91] 2002 Vietnam Intervention study Pharmacy interviews/questionnaires High 7
Al-Ghamdi MS. [92] 2001 Saudi Arabia Cross-sectional study Simulated patient method Medium 3, 7, 10, 14, 18, 20
Chalker J et al. [16] 2000 Vietnam Cross-sectional study Simulated patient method High 7, 10, 14
Wachter DA et al. [93] 1999 Nepal Cross-sectional study Simulated patient method High 7, 14, 20
Wolffers I. [94] 1987 Sri Lanka Cross-sectional study Simulated patient method Low 3, 5, 7, 9, 10, 11, 12,14, 18, 20
a Quality Assessment, Quality assessment carried out using the Appraisal tool for Cross-Sectional Studies (AXIS).
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2.4.5. Questions and Advice Made at the Time of Dispensing Antibiotics without a Prescription
The information regarding the type of questions and advice given when dispensing antibiotics
without a prescription and the resulting percentage for each is summarized in Table 4.
Among the 52 articles that used the simulated patient method, 16 mentioned the question about
possible drug allergies. Of these, seven articles presented that none of the pharmacies/pharmacists
asked this question at the time of dismissal. The remaining nine had percentages between 8.1% and
59.4%.
Seven articles mentioned the question about the concomitant use of other drugs/medication
history and, of these, two papers mentioned that none of the pharmacies/pharmacists did it at the time
of dispensation. The remaining articles mentioned percentages ranging from 2.0% to 25.0%.
The article by Hadi U et al. [80] stated that patients were never questioned before dispensing
antibiotics without prescription.
Eight articles mentioned the information provided by pharmacies/pharmacists about possible
adverse effects, with percentages ranging from 0.0% to 27.9%. Five articles mentioned that none of the
pharmacies/pharmacists provided this information.
The information given when dispensing antibiotics without a prescription about drug–drug
interactions is mentioned in three of the included articles. Of these, two articles presented percentages
of 0.0%. The third article, by Al-Tannir M. et al. [17], showed a growth in the percentage related to this
advice, increasing from 0.0% in 2011 to 51.2% in 2018.
Most of the information provided when dispensing without a prescription corresponded to
explanations of how to use antibiotics and the duration of treatment.
2.5. Study Outcomes—Articles that Used the Pharmacy Interviews/Questionnaires Method
Table 3 synthesizes the extent of antibiotic dispensation without a prescription and additional
outcomes of the studies that used the pharmacy interviews/questionnaires method.
2.5.1. Frequency of Antibiotic Dispensation without a Prescription
As in the case of articles using the simulated patient method, the articles where the pharmacy
method interviews/questionnaires were applied presented the frequency of dispensation without
a prescription in relation to the (i) total number of pharmacies (6 articles); (ii) total number of
pharmacists/pharmacy staff (23 articles), (iii) total number of interactions (2 articles) and (iv) number
of drugs dispensed without prescription (2 articles).
Of the articles indicating the frequency of dispensing antibiotics without a prescription to the total
number of pharmacists, the percentage ranged from 9.1% to 100.0% of pharmacists/pharmacy staff
who recognized dispensing antibiotics without a prescription. Four studies presented a percentage
of 100.0%, all carried out on Asian countries. Among the articles that presented the percentage
about the total number of pharmacists, eight presented the percentage referring to pharmacists who
acknowledged dispensing antibiotics without a prescription sometimes/occasionally, with percentages
varying from 5.3% to 67.3%.
Of the articles that presented the percentage in relation to the total number of visited pharmacies,
the percentage varied from 51.0% in a study conducted in Vietnam in 2002 to 100.0% in two studies,
one conducted in Zambia in 2016 and the other conducted in India in 2015.
Among the two articles that presented the percentage in relation to the total number of interactions,
it was possible to verify that the percentage varied from 26.4% to 36.4% regarding the interactions that
resulted in antibiotic dispensing without a prescription.
The remaining two articles showed the percentage of antibiotics dispensed without prescription
in relation to the number of drugs dispensed without a prescription. The article by Paes M.R. et al. [45]
showed that in 63.4% of the total dispensing encounters, 5.8% consisted of antibiotics. The article
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by Nawab A. et al. [60] revealed that out of 100 drugs dispensed without a prescription, 12.2%
corresponded to antibiotics.
2.5.2. Name/Class of Antibiotics Most Often Dispensed without a Prescription
The antibiotics most often dispensed without a prescription included amoxicillin (13 articles),
cotrimoxazole (3 articles), and amoxicillin-clavulanic acid (3 articles). Some of the articles mentioned
the most dispensed antibiotic class, instead of the most dispensed antibiotics, with classes most
commonly cited including cephalosporins (3 articles), tetracyclines (2 articles), penicillins (2 articles),
and macrolides (2 articles).
2.5.3. Types of Disease/Symptoms Most Commonly Associated with Dispensation without
a Prescription
The diseases/symptoms most commonly associated with dispensing antibiotics without
a prescription included UTI (9 articles), sore throat (8 articles), cough (7 articles), cold and flu (5 articles),
fever (5 articles), diarrhea (4 articles), wound infections (4 articles), and toothache (4 articles).
2.5.4. Questions and Advice Made at the Time of Dispensing Antibiotics without a Prescription
As in the case of articles using the simulated patient method, Table 4 also summarizes the
questions and advices provided when dispensing antibiotics without a prescription for articles using
the pharmacy interviews/questionnaires method.
The most frequently mentioned question was about the indication of the requested antibiotic
(3 articles). The percentages obtained related to this question varied from 36.0% to 94.0%.
Only one article mentioned the question about possible drug allergies, reporting that none of the
pharmacists admitted to questioning it before dispensing.
Two articles mentioned information related to possible adverse drug reactions, reporting that the
percentage of pharmacists providing this information was of 30.1% [58] and 58.0% [68]. Regarding
the articles that mentioned the advice given when dispensing, only three indicated the percentage of
pharmacists/pharmacies that do not give any advice or information. This percentage varied from 4.1%
to 66.0%.
2.6. Study Outcomes—Comparison of the Results Obtained by Using the Two Different Methods
By comparing the results obtained through the two methodologies used, it was possible to verify
that the pharmacy interview/questionnaire method showed a higher proportion of articles presenting
percentages of antibiotic dispensation without a prescription above 60.0%, when compared to the
simulated patient method (pharmacy interview/questionnaire method: 22 of 36 articles; simulated
patient method: 29 of 52 articles).
Only 1 of the 52 articles using the simulated patient method recorded that in all pharmacies visited
the antibiotic was obtained without a prescription, that is, a percentage of 100.0%. In contrast, six
articles using the pharmacy interview/questionnaire method reported that 100.0% of the interviewed
pharmacists/pharmacy staff acknowledged dispensing antibiotics without a prescription.
Regarding the antibiotics most commonly dispensed without a prescription, it was possible to verify
that amoxicillin was the one most distributed in the two different methods. Moreover, the same also
happened with amoxicillin-clavulanic acid. The remaining most dispensed antibiotics differed in the
two methods, with articles using a simulated patient method mentioning azithromycin and ciprofloxacin
and articles using the pharmacy interview/questionnaire method mentioning cotrimoxazole.
Additionally, it turns out that the diseases/symptoms most used in the simulated patient method
were equivalent to the diseases/symptoms most commonly mentioned by pharmacists/pharmacy staff
surveyed in the pharmacy interview/questionnaire method.
Table 5 shows the comparison of the frequency of dispensing antibiotics without a prescription
obtained within each country using the different methods. The table summarizes the number of
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studies carried out in the indicated countries, as well as their nature (if a simulated patient method
or a pharmacy interview/questionnaire method was used), together with the frequency values of
antibiotic dispensing recorded in each study, thus allowing us to analyze the trend of data over time.
For example, it was possible to verify that six articles were conducted in Saudi Arabia, with three
using the simulated patient method, 2 using the pharmacy interview/questionnaire method and 1
using both methods. The articles that used the simulated patient method revealed an increase in the
frequency of dispensing antibiotics without a prescription from 82.0% [92] to 97.9% [78] and then
a slight decrease to 92.2% [34]. The study by Al-Tannir M. et al. [17] registered the lowest value both in
2011 (77.6%) and 2018 (12.5%).
Regarding the articles that used the pharmacy interview/questionnaire method, it was possible to
verify that the percentage registered remained at the value of 100.0% for pharmacists who recognized
dispensing antibiotics without a prescription [41,68]. Conversely, there was a decrease to 70.7% in the
study by Alrasheedy AA. et al. [34]
In Ethiopia, it was possible to observe a decrease in the frequency of dispensing antibiotics
without a prescription between studies published in 2016 and 2019, when using the pharmacy
interview/questionnaire method [11,56]. However, the same did not happen with studies using the
simulated patient method, where it was possible to observe an increase between the study published
in 2016 and the studies published in 2019 [11,14,35,37].
When analyzing the data referring to the three articles [11,34,86] that used both methods, it was
possible to verify that in two of them [11,34], the highest percentage of antibiotic dispensation
without a prescription was associated with the simulated patient method, in the article by Alrasheedy
AA. et al. [34] carried out in Saudi Arabia (92.2% versus 70.7%) and the article by Mengistu G et al. [11]
conducted in Ethiopia (86.7% versus 50.5%). Alternatively, the article by Nyazema N et al. [86] carried
out in Zimbabwe presented a higher percentage of antibiotic dispensation without a prescription
associated with the pharmacy interview/questionnaire method (8.0% in the simulated patients method
versus 31.0% in the pharmacy interview/questionnaire method).
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Level of Insistence by
Patients and the Percentage
of Antibiotic Dispensation
without a Prescription at
Each Level
Al-Tannir M. et al.
(2020) [17]
2011: 327
PH 2011: 77.6%, n = 254
Sore throat: Amoxicillin/clavulanic acid (n = 32),
azithromycin (n = 11) and amoxicillin (n = 9)
Acute sinusitis: Amoxicillin/clavulanic acid (n = 22),
azithromycin (n = 10), amoxicillin (n = 3), cefaclor
(n = 1), ofloxacillin (n = 1) and others (n = 1)
Otitis media: Amoxicillin/clavulanic acid (n = 12),
amoxicillin (n = 8), cephalexin (n = 4), azithromycin
(n = 1), cefaclor (n = 1) and cefixime (n = 1)
Acute bronchitis: Amoxicillin/clavulanic acid
(n = 15), amoxicillin (n = 9), azithromycin (n = 5) and
others (n = 6)
Diarrhea: Metronidazole (n = 51), ciprofloxacin
(n = 3), cotrimoxazole (n = 1), ofloxacin (n = 1) and
others (n = 1)
UTI: Ciprofloxacin (n = 39), amoxicillin (n = 2),
cefixime (n = 1), clarithromycin (n = 1) and others
(n = 1)




Three levels of demand: level
1 (Can I have something to
relieve my symptoms?), level
2 (Can I have something
stronger?), level 3 (I would
like to have an antibiotic.)
2018: 327
PH 2018: 12.5%, n = 41
Sore throat: Amoxicillin/clavulanic acid (n = 5),
azithromycin (n = 1) and amoxicillin (n = 2)
Acute sinusitis: Amoxicillin (n = 1)
Otitis media: Amoxicillin/clavulanic acid
Acute bronchitis: Amoxicillin/clavulanic acid (n = 2),
azithromycin (n = 1), amoxicillin (n = 1)
Diarrhea: Metronidazole (n = 17)
UTI: Ciprofloxacin (n = 4), nitrofurantoin (n = 1),
sulfamethoxazole (n = 1) and trimethoprim (n = 1)




Three levels of demand: level
1 (Can I have something to
relieve my symptoms?), level
2 (Can I have something
stronger?), level 3 (I would
like to have an antibiotic.).
All the obtained antibiotics
were dispensed under level 3















Level of Insistence by
Patients and the Percentage
of Antibiotic Dispensation
without a Prescription at
Each Level
Bahta M. et al.






Ciprofloxacin (n = 65, 47.8%), cotrimoxazole (n = 51,
37.5%), amoxicillin (n = 11, 8.1%), doxycycline (n = 5,
3.7%), tinidazole (n = 3, 2.2%) and metronidazole
(n = 1, 0.7%).
Uncomplicated UTI: Ciprofloxacin (n = 38, 56.7%),
cotrimoxazole (n = 14, 20.9%), amoxicillin (n = 11,
16.4%), doxycycline (n = 3, 4.5%) and tinidazole (n = 1,
1.5%)
Acute watery diarrhea: Ciprofloxacin (n = 27, 39.1%),
cotrimoxazole (n = 37, 53.6%), doxycycline (n = 2,
2.9%), tinidazole (n = 2, 2.9%) and metronidazole
(n = 1, 1.4%)
UTI and acute watery
diarrhea
Three levels of demand: level
1 (Asked for some drugs to
alleviate the symptoms)
(81.3%), level 2 (Request for
unspecified antibiotics)
(11.2%), level 3 (Ask
pharmacy attendant for
a specific type of antibiotics)
(6.7%)
Chen J. et al.
(2020) [28] 1106 PH 83.6%, n = 925
Penicillins (n = 333, 36.0%), cephalosporins (n = 274,




Three levels of demand: level
1 (Symptoms only described)
(25.2%), level 2 (Asked for
antibiotics) (52.1%), level 3
(Asked for penicillin or
cephalosporins) (6.3%).








Name/Class of Antibiotics Most Often






Level of Insistence by Patients
and the Percentage of Antibiotic
Dispensation without
a Prescription at Each Level





73.3%, n = 733
Sore throat: 99.5%,
n = 199





UTI: 48%, n = 96
Penicillin (48.3%), sulfonamide (12.5%), macrolide
(10.6%), fluoroquinolones (8.8%), chloramphenicol
(0.3%)
Sore throat, otitis media,
cough, diarrhea, and UTI
Three different levels of demand:
level 1 (Asked for medications to
relieve the symptoms), level 2
(Asked for a stronger medication),
level 3 (Asked for an antibiotic)
Sore throat: level 1 (n = 195,
98.0%), level 2 (n = 2, 1.0%), level
3 (n = 2, 1.0%)
Cough: level 1 (n = 14, 7.6%),
level 2 (n = 101, 55.0%), level 3
(n = 69, 37.5%)
Diarrhea: level 1 (n = 121, 80%),
level 2 (n = 22, 14.5%), level 3
(n = 8, 5.3%)
Otitis media: level 1 (n = 78,
75.0%), level 2 (n = 25, 24%), level
3 (n = 1, 1%)
UTI Level 1 (n = 75, 78%), level 2
(n = 19, 19.8%), level 3 (n = 2,
2.0%).











Pediatric case: Cephalosporin (35.8%),
azithromycin (29.6%) and roxithromycin (16.1%)
Adult case: Azithromycin (30.0%), cephalosporin
(28.0%) and roxithromycin (26.0%)
Pediatric and adult acute
cough associated with
a common cold
Three levels of demand: level 1
(Client required some medicine
for cough) (22.5%), level 2 (Client
explicitly expressed the
requirement of antibiotics)
(60.5%), level 3 (Client specifically
required roxithromyci) (5.4%)
Pediatric case: level 1 (n = 15,
20.6%), level 2 (n = 39, 53.4%),
level 3 (n = 4, 5.5%).
Adult case: level 1 (n = 18,
24.3%), level 2 (n = 50, 67.6%),
level 3 (n = 4, 5.4%).















Level of Insistence by
Patients and the Percentage
of Antibiotic Dispensation
without a Prescription at
Each Level
Wang X. et al.
(2020) [32] 120 PH/V 73.3%, n = 88
Norfloxacin (n = 60), gentamicin (n = 13), levofloxacin
(n = 8), ciprofloxacin hydrochloride (n = 8),
cefotaxime (n = 1), oxytetracycline (n = 1) and
trimethoprim (n = 1)
Acute diarrhea
Two levels of demand: level 1
(“Hi, I have suffered from
diarrhea since yesterday,
please give me some
medicine.”) (55%), level 2
(“Hi, I have suffered from
diarrhea since yesterday,
and I am here to buy
antibiotics.”) (91.7%)










97.6%, n = 122
Common cold: 99.1%,
n = 112












UTI: 87.7%, n = 50
Pharyngitis and UTI
Three levels of demand: level
1 (Asked for something to
relieve the symptoms), level 2
(Asked for something
stronger), level 3 (Simulated
patient directly requested an
antibiotic)
Pharyngitis: level 1 (85.7%),
level 2 (5.4%), level 3 (8.9%)
UTI: level 1 (74.0%), level 2
(8.0%), level 3 (18.0%)















Level of Insistence by
Patients and the Percentage
of Antibiotic Dispensation
without a Prescription at
Each Level







URTI: 70.1%, n = 1690
Amoxicillin and cephalosporins Paediatric diarrhoea andadult acute URTI
Three levels of demand: level
1 (“Can you give me some
medicine to alleviate the
patient’s symptoms?”), level 2
(“Can you give me some
antibiotics?”), level 3 (“I
would like some amoxicillin
or cephalosporins.”)
Diarrhoea: level 1 (n = 142,
5.9%), level 2 (n = 685, 28.4%),
level 3 (n = 342, 14.2%)
URTI: level 1 (n = 321, 13.3%),
level 2 (n = 888, 36.8%) and
level 3 (n = 481, 20.0%)
Damisie G et al.
(2019) [35] 18 DS




88.9%, n = 16
UTI: 94.4%, n = 17
Sore throat: Amoxicillin (n = 10, 71.4%), azithromycin
(n = 3, 21.4%), amoxicillin/azithromycin (n = 1, 7.2%)
Acute diarrhea: Metronidazole (n = 8, 50.0%),
rifampicin (n = 4, 25.0%), tinidazole (n = 2, 12.5%) and
ciprofloxacillin/tinidazole/metronidazole (n = 2,
12.5%)
UTI: Ciprofloxacin (38.90%), norfloxacin (33.30%),
cotrimoxazole (16.70%) and amoxicillin (5.60%)
Sore throat,
acute diarrhea, and UTI
Three levels of demand: level
1 (Asking something to
alleviate his/her symptoms),
level 2 (Asking for a stronger
medication), level 3 (Clear
request for an antibiotic in the
case of not achieving the
previous two levels of
demand)
Sore throat: level 1 (n = 14,
100%), level 2, level 3 (0%)
Acute diarrhea: level 1
(n = 11, 68.75%), level 2 (n = 3,
18.75%), level 3 (n = 2, 12.5%)
UTI: level 1 (n = 16, 94.1%),
level 2 (n = 1, 5.9%), level 3
(0%)















Level of Insistence by
Patients and the Percentage
of Antibiotic Dispensation
without a Prescription at
Each Level
Koji EM et al.
(2019) [37] 262 PH 63.4%, n = 166
Amoxicillin, amoxicillin-clavulanate, azithromycin,
trimethoprim/sulfamethoxazole, metronidazole,
ceftriaxone, cloxacillin, vancomycin, ampicillin,
cefotaxime, gentamicin
Common cold, acute onset
diarrhea, pneumonia
(child), meningitis (child)
Mengistu G et al.
(2019) [11] a 105 PH 86.7% Cotrimoxazole (97.8%)
Acute watery diarrhea
(child)












Fever: Bromhexine (n = 1), cetirizine (n = 1),
chlorpheniramine (n = 7), levocetirizine (n = 1),
montelukast (n = 1)
URTI: Bromhexine (n = 8), cetirizine (n = 11),
chlorpheniramine (n = 45), dextromethorphan
(n = 45), levocetirizine (n = 2), levosalbutamol (n = 2),
montelukast (n = 1), salbutamol (n = 2), terbutaline
(n = 1)
Diarrhoea: Loperamide (n = 23)
AdultsFever: Bromhexine (n = 9), cetirizine (n = 65),
chlorpheniramine (n = 53), dextromethorphan (n = 4),
levocetirizine (n = 3), nimesulide (n = 23)
URTI: Bromhexine (n = 109), cetirizine (n = 8),
chlorpheniramine (n = 115), dextromethorphan
(n = 62), levocetirizine (n = 13), montelukast (n = 5),
salbutamol (n = 1), terbutaline (n = 26)
Diarrhoea: Domperidone (n = 2), loperamide
(n = 227), omeprazole (n = 3), ranitidine (n = 2)
URTI, uncomplicated
acute diarrhoea, and acute
febrile illness suggestive
of malaria















Level of Insistence by
Patients and the Percentage
of Antibiotic Dispensation
without a Prescription at
Each Level
Zawahir S et al.
(2019) [38] 242 PH





Sore throat: Erythromycin (n = 17, 65%),
azithromycin (n = 7, 27%;), ciprofloxacin (n = 1, 4%),
amoxicillin (n = 1, 4%) Common cold: Amoxicillin
(89%; n = 8) and others (n = 1, 11%)
Diarrhoea: Metronidazole (n = 23, 79%), ciprofloxacin
(n = 2, 7%), erythromycin (n = 2, 7%), azithromycin
(n = 1, 3%) and others (n = 1, 3%).
UTI: Ciprofloxacin (n = 26, 76%), norfloxacin (n = 5,
15%), others (n = 3, 9%)
Viral infections:
acute sore throat, common
cold (child), and acute
diarrhoea and bacterial
uncomplicated UTI
Three levels of demand: level
1 (Can I get some medicine to
alleviate the symptoms?)
(n = 39, 16%), level 2 (Can I
get something stronger?)
(n = 33, 14%), level 3 (I would
like an antibiotic.) (n = 27,
11%).
Sore throat: level 1 (n = 11,
18%), level 2 (n = 7, 12%),
level 3 (n = 8, 13%)
Common cold: level 1 (n = 1,
2%), level 2 (n = 6, 10%), level
3 (n = 2, 3%)
Diarrhoea: level 1 (n = 9,
15%), level 2 (n = 11, 18%),
level 3 (n = 10, 17%)
UTI: level 1 (n = 18, 29%),
level 2 (n = 9, 15%), level 3
(n = 7, 11%)





86.0%, n = 86
Childhood diarrhea:
n = 40 (Pharmacy:
(75%, n = 21/28); drug
store: 86.4%,
n = 19/22);
URTI: n = 46
(Pharmacy: 85.7%,
n = 24/28; drug store:
100%, n = 22/22)
Childhood diarrhea: Cotrimoxazole (n = 11),
metronidazole (n = 15)
URTI: Amoxicillin (n = 23), amoxicillin-clavulanic
acid (n = 19), azithromycin (n = 15), ciprofloxacin
(n = 5), cephalexin (n = 1), cefexime (n = 1),
levofloxacin (n = 3)
Acute childhood diarrhea
and URTI
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Amoxycillin (n = 1), ampiclox (n = 3),
trimethoprim/sulphamethoxazole (n = 2), cefixime
(n = 1), amoxyclav, (n = 1), azithromycin (n = 4),




Ibrahim IR et al.
(2018) [12] a 75 PH 20.0%, n = 15
Metronidazole (n = 4, 5.3%), furazolidone (n = 3,
4.0%) Acute diarrhea
Mohamed Ibrahim



















throat with phlegm and
slight cough when in bed)
Zapata-Cachafeiro
M et al. (2018) [48] 977 PH 18.8%, n = 184
Amoxicillin (n = 127, 69.0%),
amoxicillin-clavulanic acid (7%), azithromycin
(n = 42, 22.8%), cotrimoxazole (n = 7, 3.8%),
moxifloxacin (n = 4, 2.2%), cefuroxime (n = 2,
1.1%), clarithromycin (n = 1, 0.5%) and
clindamycin (n = 1, 0.5%)
Sore throat, difficulty
swallowing, and feeling
feverish, in addition to
congestion and cough
Four levels of demand: level 1
(Request for medication to
relieve the symptoms)
(2.97%), level 2 (Request for
a stronger medication than
that offered) (4.22%), level 3
(Request for an antibiotics)
(4.52%), level 4 (Specific
request for amoxicillin)
(8.54%)















Level of Insistence by
Patients and the Percentage
of Antibiotic Dispensation
without a Prescription at
Each Level
Zawahir S et al.
(2018) [49] 242 PH 61.0%, n = 147
Ciprofloxacin (n = 44, 70%), erythromycin,
metronidazole, amoxicillin (n = 32, 52%)
URTI (adult and child),
watery diarrhoea and UTI
Chang J. et al.
(2017) [52] 256 PH
66.8%
Paediatric diarrhoea:
55.9%, n = 143
Adult acute URTI:
77.7%, n = 199
Paediatric diarrhoea and
adult acute URTI
Three levels of demand: level
1 (“Can you give me some
drugs to alleviate the
symptoms of the disease?”),
level 2 (“Can you give me
some antibiotics?”), level 3 (“I
would like some amoxicillin
or cefaclor.”)
Paediatric diarrhoea: Level 1
(9%), level 2 (37.5%), level 3
(9.4%)
Acute URTI: level 1 (26.2%),
level 2 (43.0%), level 3 (8.6%)
Jaisue S. et al.
(2017) [21] b
91 class I
PH 68.1%, n = 62
Furazolidone (n = 31, 34.1%), nifuroxazide (n = 17,
18.7%), cotrimoxazole (n = 10, 11.0%), metronidazole
(n = 2, 2.2%), cephalexin (n = 2, 2.2%), azithromycin
(n = 1, 1.1%), norfloxacin (n = 1, 1.1%)
Non-infectious diarrhoea
in a 14-month-old child
Marković-Peković
V et al. (2017) [18]
2010: 131
PH 2010: 58.0%, n = 76
2010: Amoxicillin (n = 65, 85.5%), ampicillin (n = 5,
6.6%),
cephalexin (n = 2, 2.6%) and doxycycline (n = 4, 5.3%)
URTI
2015: 383
PH 2015: 18.5%, n = 71
2015: Amoxicillin (n = 57, 80.3%), ampicillin (n = 9,
12.7%),
cephalexin (n = 3, 4.2%), azithromycin (n = 1, 1.4%)
and amoxicillin and enzyme inhibitor (n = 1, 1.4%)
URTI
Okuyan B. et al.
(2017) [54] 70 PH
Antibiotic + NSAIDs
(n = 15, 21.4%)
Antibiotic alone
(n = 17, 24.2%)
Cefuroxime alone (n = 5), cefuroxime with other
medication (n = 6), amoxicillin-clavulanic acid alone
(n = 12), amoxicillin-clavulanic acid with other
medication (n = 9)
Acute uncomplicated
rhinosinusitis
Abegaz T.M. et al.
(2016) [14] a 113 PH 51.3%, n = 58 Cotrimoxazole and metronidazole Acute diarrhea















Level of Insistence by
Patients and the Percentage
of Antibiotic Dispensation
without a Prescription at
Each Level
Guinovart MC et al.
(2016) [57] 220 PH 54.1%, n = 119 β-lactam antibiotic and amoxicillin-clavulanic acid
UTI, sore throat,
and acute bronchitis
Four levels of demand: level 1
(Medication to treat the
symptoms was required),
level 2 (A stronger medication
was required), level 3 (An
antibiotic was required), level
4 (A specific antibiotic was
required:
amoxicillin/clavulanic acid for
a UTI and amoxicillin for
a sore throat and acute
bronchitis)





43.2%, n = 41
Nifuroxazide (n = 21, 22.11%), metronidazole alone
(n = 12, 12.63%), metronidazole with other medication
(n = 4, 4.21%), tinidazole (n = 2, 2.11%), furazolidone
(n = 1, 1.05%)
Acute gastroenteritis
Satyanarayana S. et al.
(2016) [61]
622 PH,
1200 V 27.0%, n = 319
Presumed tuberculosis: Amoxicillin (n = 100),
ofloxacin (n = 25), ciprofloxacin (n = 24), azithromycin
(n = 23), cefixime (n = 19), levofloxacin (n = 14),
ampicillin (n = 8), roxithromycin (n = 8), cloxacillin
(n = 6), erythromycin (n = 6)
Tuberculosis case with positive sputum report:
Amoxicillin (n = 50), azithromycin (n = 16), cefixime
(n = 11), levofloxacin (n = 7), ofloxacin (n = 7),
ciprofloxacin (n = 5)
Tuberculosis
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48.5%, n = 15
Diarrhea: 81.0%,
n = 34
UTI: 83.3%, n = 35
Sore throat: Penicillins (45%),
penicillin/penicillinase inhibitor (32.5%),
first-Gen cephalosporins (10%)
Otitis media: choramphenicol (19.2%),
penicillins (15.4%), macrolides (11.5%)
Acute sinusitis: Penicillins (20%),




UTI: fluoroquinolones (80%), third-Gen
cephalosporins (5.7%)
Sore throat, otitis media,
acute sinusitis, diarrhea,
and UTI
Three levels of demand: level 1
(Asking for something to alleviate the
symptoms) (n = 121, 59.9%), level 2
(Asking for a stronger medication)
(n = 4, 2%), level 3 (Clear request for
an antibiotic) (n = 25, 12.4%)
Sore throat: level 1 (n = 39, 95.1%),
level 2 (n = 0), level 3 (n = 1, 2.4%)
Otitis media: level 1 (n = 25, 65.8%),
level 2 (n = 0), level 3 (n = 1, 2.6%)
Acute sinusitis: level 1 (n = 3, 7.7%),
level 2 (n = 4, 10.3%), level 3 (n = 8,
20.5%)
Diarrhea: level 1 (n = 24, 57.1%),
level 2 (n = 0) and level 3 (n = 10,
23.8%)
UTI: level 1 (n = 30, 71.4%), level 2
(n = 0), level 3 (n = 5, 11.9%)







66.7%, n = 174
URTI: 71.3%, n = 82;
Acute gastroenteritis
(child): 63.0%, n = 92
URTI: Amoxicillin (n = 42, 51.2 %),
amoxicillin-clavulanate (n = 2, 2.4%),
ampicillin-cloxacillin (n = 4, 4.9%),
cephalexin (n = 2, 2.4%), cefixime (n = 2,
2.4%), azithromycin (n = 10, 12.2%),
roxithromycin (n = 3, 3.7%), ciprofloxacin
(n = 10, 12.2%), levofloxacin (n = 3, 3.7%)
and ofloxacin (alone) (n = 4, 4.9%)
Acute gastroenteritis (child): Ofloxacin
(alone) (n = 7, 7.6%), norflaxacin (alone)
(n = 8, 8.7%), norfloxacin +
metronidazole (n = 38, 41.3%), ofloxacin
+ metronidazole (n = 9, 9.8%), ofloxacin +
ornidazole (n = 7, 7.6%), metronidazole
(alone) (n = 14, 15.2%) and furazolidone
(n = 9, 9.8%)
URTI (adult) and acute
gastroenteritis (child)
Two levels of demand: level 1
(Request for a “medicine” to alleviate
the described symptoms) (55.6%),
level 2 (Specifically asked for
a “stronger” medicine) (44.4%)
URTI infection: level 1 (53.9%), level
2 (17.4%)
Acute gastroenteritis (child): level 1
(56.8%), level 2 (6.2%)















Level of Insistence by
Patients and the Percentage
of Antibiotic Dispensation
without a Prescription at
Each Level
Alabid A.H.M.A. et al.
(2014) [67]
50 PH/Ph,
100 V 32.0%, n = 32
Amoxil and Amoxiclav (n = 11, 11.0%), erythromycin
(n = 9, 9.0%), cefalexin (n = 4, 4.0%)
Common cold symptoms
(symptoms of URTI)
Malik M. et al.
(2013) [15] a 238 PH/V
Simulated patients
were treated in 198 V
(83.1%); antibiotics














chloramphenicol, procaine penicillin, tetracycline
Cough, headache and
diarrhea (“typhoid”,
child), injured on the left








a bad smell (“gonorrhea”)
Marković-Peković
V et al. (2012) [74] 131 PH 58.0%, 76 pharmacies
Amoxicillin (85%), doxycyline (5%), ampicillin (7%),
and cefalexin (3%) URTI
Without insistence in case of
refusal





51.7%, n = 31
Amoxicillin (n = 19, 31.7%), erythromycin (n = 1,
1.7%), ampicillin+cloxacillin (n = 1, 1.7%),
azithromycin (n = 4, 6.7%)
URTI, acute bronchitis,
and diarrhoea
Two levels of demand: Level
1 (Can I have something for
my symptoms?) and level 2 (I
would like an antimicrobial
agents.)
URTI: level 1 (35%), levels 2
and 3 (40%)
Acute bronchitis: level 1
(20%), level 2 and level 3
(30%)
Diarrhoea: level 1 (20%),
levels 2 and 3 (10%)















Level of Insistence by
Patients and the Percentage
of Antibiotic Dispensation
without a Prescription at
Each Level
Simó S et al.
(2012) [76] 50 PH 8.0%, n = 4 Amoxicillin/clavulanic acid (n = 4, 8%) URTI symptoms and fever
Al-Faham Z et al.
(2011) [77] 200 PH 97.0%, n = 194
Amoxicillin/clavulanic acid 1000 mg (n = 73, 37.6%);
amoxicillin (n = 45, 23.1%); amoxicillin/clavulanic acid
625 mg (n = 25, 12.8%); amoxicillin/floxacillin (n = 13,
6.7%), cefodroxil (n = 13, 6.7%), clarithromycin (n = 6,
3.0%), azithromycin (n = 5, 2.5%), ciproflaxacillin
(n = 4, 2.0%), Cloxacillin/Ampicillin (n = 4, 2.0%),
cefixime (n = 2, 1.0%), cefprodoxime 100mg (n = 2,
1.0%) and cefprodoxime 200mg (n = 2, 1.0%)
Sinusitis (fever, runny
nose with clear secretion
and a headache in the
frontal sinus region)
Two levels of demand: level 1
(without insistence) (n = 174,
87%), level 2 (with insistence)
(n = 20, 10%)
Al-Mohamadi A et al.
(2011) [78] 60 PH/Ph 97.9%
Co-amoxiclav (Augmentin), amoxicillin-clavulanic
acid, cefaclor Sore throat






91.0%, n = 80 Ciprofloxacin (n = 80, 91%), tetracycline (n = 80, 91%),amoxicillin (n = 74, 84%)
“discomfort on urination”,
infected leg wounds and
“productive cough, rainy
nose, fever and lost of
appetite”






75.9%, n = 79
Amoxicillin (n = 15), chloramphenicol (n = 18),
ciprofloxacin (n = 14), cotrimoxazole (n = 14),
tetracycline 250 mg (n = 15), tetracycline 500 mg
(n = 2)












16.9%, n = 10
UTI: 79.7%, n = 55
Sore throat, acute
bronchitis, and UTI
Three levels of demand: level
1 (Asked for something to
alleviate the symptoms of the
infection), level 2 (“This
medication is not very strong,
can’t you give me something
stronger?”), level 3 (Asking
openly for an antibiotic)















Level of Insistence by
Patients and the Percentage
of Antibiotic Dispensation
without a Prescription at
Each Level














100.0%, n = 72
Ciprofloxacin (n = 54, 53%), amoxicillin/clavulanic
acid (n = 72, 100%)
Without insistence in case of
refusal







I (non-Ph + Ph):
26.0%, n = 25
I (non-Ph): 30.3%,
n = 10
II: 21.1%, n = 4
Antibiotics only
I (non-Ph + Ph):
21.9%, n = 21
I (non-Ph): 27.3%,
n = 9
II: 26.3%, n = 5
Antibiotics+
combined drugs
I (non-Ph + Ph): 1.0%,
n = 1
I (non-Ph): 3.0%, n = 1
II: n = 1, 5.3%
Pharmacy personnel: Nifuroxazide, cotrimoxazole,
norfloxacin, erythromycin and amoxicillin
Acute childhood
diarrhoea
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16.9%, n = 10
UTI: 79.7%, n = 55
Sore throat: Amoxicillin (n = 21, 87.5%),
amoxicillin/clavulanic acid (n = 2, 8.3%),
azithromycin (n = 1)
Acute bronchitis: Amoxicillin (n = 10)
UTI: Norfloxacin (n = 22, 40.0%), fosfomycin
trometamol (n = 20, 36.4%), pipemidic acid




Three levels of demand: level
1 (“Can you give me
something to alleviate the
symptoms of the infection?”)
(n = 65, 33.0%), level 2 (“Can’t
you give me something
stronger?”) (n = 17, 8.6%),
level 3 (“I would like an
antibiotic.”) (n = 7, 3.6%)
Sore throat: level 1 (n = 12,
17.4%), level 2 (n = 10, 14.5%),
level 3 (n = 2, 2.9%)
Acute bronchitis: level 1
(n = 1, 1.7%), level 2 (n = 5,
8.5%), level 3 (n = 4, 6.8%)
UTI: level 1 (n = 52, 75.4%),
level 2 (n = 2, 2.9%), level 3
(n = 1, 1.4%)









SCM-female: Doxycycline (n = 23), amoxicillin
(n = 5), sulfamethoxazole/trimethoprim (n = 13),
erythromycin (n = 1), ciprofloxacin (n = 15),
metronidazole (n = 16), nitrofurantoin (n = 1)
SCM-male: Doxyxycline (n = 40), amoxicillin
(n = 3), phenoxymethylpenicillin (n = 2),
sulfamethoxazole/trimethoprim (n = 13),
erythromycin (n = 1), ciprofloxacin (n = 30),




















male) and acute diarrhoea
(child)















Level of Insistence by
Patients and the Percentage
of Antibiotic Dispensation
without a Prescription at
Each Level
Volpato DE et al.
(2005) [88] 107 PH 74.0%
Amoxicillin (n = 46, 74%), azythromycin (n = 6, 9.6%),
sulfamethoxazole/trimethoprim (n = 5, 8.1%),
cephalexin (n = 2, 3.2%), erythromycin (n = 2, 3.2%)
and ampicillin (n = 1, 1.6%)
Acute and uncomplicated
rhino-sinusitis
Three levels of demand: No
insistence (58%), insisting
once (13%) or twice (3%)
when the antibiotic was
denied.








PHN:100.0%, n = 34
PBNHN and
PWNHN: 0.0%
Ampicillin (n = 26, 76.5%), ampicillin and tetracycline
(n = 2, 5.9%), ampicillin and erythromycin;
amoxicillin (n = 2, 5.9%), erythromycin (n = 1, 2.9%)
Sore throat
Al-Ghamdi MS.
(2001) [92] 88 PH 82.0%, n = 72
Fluoroquinolones (First choice: n = 50, 69% and
Second choice: n = 59, 87%), cotrimoxazole (First
choice: n = 9, 13% and Second choice: n = 3, 4%),
penicillins (First choice: n = 8, 11% and Second choice:
n = 3, 4%), cephalosporins (First choice: n = 3, 4% and
Second choice: n = 1, 2%), tetracyclins (First choice:
n = 2, 3% and Second choice: n = 2, 3%)
Uncomplicated lower, UTI
Chalker J et al.
(2000) [16] a
60 PH,
297 V 81.5%, n = 242
Tetracyclines (n = 36), amphenicols (n = 14), β-lactam
antibacterials- Penicillins (n = 10), other β- lactam
antibacterials (16), sulphonamides/trimethoprim
(n = 6), macrolides and lincosamides (n = 15),
quinolones (n = 188), metronidazole (n = 3),
spectinomycin (n = 4), drugs for treatment of TB
(n = 1)
STD
Wachter DA et al.




Dysuria: Norfloxacin (28%), amoxicillin (5%),




metronidazole/nalidixic acid (comb) (9%),
metronidazole/nalidixic acid (separate) (2%)
Dysuria and acute watery
diarrhoea (child)















Level of Insistence by
Patients and the Percentage
of Antibiotic Dispensation
without a Prescription at
Each Level
Wolffers I. (1987) [94] 28 PH 100.0% Tetracyclin (100%)
Sample size: PH, Pharmacies; Ph, Pharmacists; V, Visits; DS, DrugStores; MRO, Medicine Retail Outlets; INT, Interactions; DD, Drugs Dispensed; ADDO, Accredited Drug Dispensing
Outlets; DLDB, Duka la Dowa Baridi; K, Kiosk; PHN, Primarily Hispanic Neighborhood; PBNHN, Primarily Black Non- Hispanic Neighborhood; PWNHN, Primarily White Non-Hispanic
neighborhood; Types of disease/symptoms most commonly associated with dispensation without a prescription: UTI, Urinary Tract Infection; URTI, Upper Respiratory Tract Infection; STD,
Sexually Transmitted Diseases; a Articles that do not explicitly mention throughout the full article that it is about dispensing antibiotics without a prescription, but rather the management
of diseases/symptoms in pharmacies/drug stores; b Articles showing the frequency of dispensing antibiotics without a prescription for class I and class II pharmacies. Class I pharmacies
are legally authorized to dispense antibiotics without a prescription.
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Table 3. Study Outcomes—articles that used the Pharmacy interviews/questionnaires.
Authors (Year) Sample Size Frequency of AntibioticDispensation without a Prescription
Name/Class of Antibiotics Most Often
Dispensed without a Prescription
Types of Disease/Symptoms Most
Commonly Associated with
Dispensation without a Prescription
Abubakar U. et al.
(2020) [24] 98 Ph
PD: 74.5% (n = 73)
PSD: 67.3% (n = 66)
Penicillin (n = 84, 85.7%), tetracycline
(n = 69, 70.4%), cephalosporin (n = 63,
64.3%), quinolone (n = 61, 62.2%),
macrolides (n = 54, 55.1%), sulphonamides
(n = 47, 48.0%), aminoglycosides (n = 34,
34.7%), carbapenems (n = 13, 13.3%.
UTI, typhoid fever, genital infections
(gonorrhea), wound infections, eye
infections, ear infections, diarrhea, malaria,
toothache, and cold/flu
Abubakar U.
(2020) [25] 98 Ph
PD: 96.9% (n = 95)
PSD: 60.2% (n = 59)
Badro D.A. et al.
(2020) [26] 250 Ph
88.0% acknowledged dispensing
medications without a prescription,
those medications included
antibiotics (60.0%)
Gajdács M. et al.
(2020) [29] 192 Ph PD: 26.0%
Alrasheedy AA. et al.
(2019) [34] 116 PH 70.7%, n = 82
Hallit S et al.
(2019) [36] 280 PH, 202 Ph 84.6%
Pharyngitis, otitis media, diarrhoea,
and vomiting (child)
Mengistu G et al.
(2019) [11] a 105 PH/PS 50.5% Acute watery diarrhea (child)
Zawahir S. et al.
(2019) [39] 265 PS
31.7%, n = 84
Non-Ph: 33.3%, n = 18;
Ph: 31.6%, n = 66
Acute sore throat, common cold, acute
diarrhoea, wound infection, or
uncomplicated UTI
Ajie A.A.D. et al.
(2018) [40] 190 PH PD: 92.1% (n = 175)
Amoxicillin (n = 175, 92.1%), cotrimoxazole
(n = 175, 92.1% and ciprofloxacin (n = 159,
83.7%)
Alhomoud F et al.
(2018) [41] 20 Ph 100.0%
Amoxicillin/clavulanic Acid (Augmentin),
amoxicillin and azithromycin. Fever, sore throat, cold/flu, and cough.
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Authors (Year) Sample Size Frequency of AntibioticDispensation without a Prescription
Name/Class of Antibiotics Most Often
Dispensed without a Prescription
Types of Disease/Symptoms Most
Commonly Associated with
Dispensation without a Prescription
Awosan KJ et al.
(2018) [42] 197 PS
PD: 91.9% (n = 181)
PSD: 10.2% (n = 20)
Paes M.R. et al.
(2018) [45] 101 Ph
Dispensing without a prescription
was 63.4% of the total dispensing
encounters, those medications
included antibiotics (5.8%)
Rehman IU et al.
(2018) [46] 181 Ph
PD: 68.0% (n = 123)
PSD: 20.4% (n = 37)
Sarwar M.R. et al.
(2018) [47] 400 Ph
PD: 93.7% (n = 375)
PSD: 34.5% (n = 138)
Ansari M. (2017) [50] 16 PH 66.5% Cephalosporins, penicillins,and macrolides
Respiratory tract complications (e.g.,
cough), fever, and UTI
Barker A.K. et al.
(2017) [51] 24 PS 100.0%
Colds, viral infections, coughs, and sore
throat
Mansour O et al.
(2017) [53] 173 PH 85.5% Tonsillitis
Abood EA et al.
(2016) [55] 170 Ph 25.3%, n = 43 Amoxicillin (7.3%)
Erku D.A. (2016) [56] 389 Ph PD: 90.2%PSD: 5.4% (n = 21)
Kalungia AC et al.
(2016) [58] 73 PH 100%
Amoxicillin (n = 38, 52.1%), cotrimoxazole
(n = 18, 24.7%), metronidazole (n = 17,
23.3%)
Khan M.U. et al.
(2016) [59] 188 Ph
PD: 63.3% (n = 119)
PSD: 5.3% (n = 10)
Nawab A. Et al.
(2016) [60] 50 PH





(2015) [63] 147 Ph 100.0%
Amoxicillin, amoxicillin/clavulanic acid,
cephalexin Sore throat and UTI
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Authors (Year) Sample Size Frequency of AntibioticDispensation without a Prescription
Name/Class of Antibiotics Most Often
Dispensed without a Prescription
Types of Disease/Symptoms Most
Commonly Associated with
Dispensation without a Prescription
Dorj G. et al.
(2015) [64] 61 PS
PSD: 21.7% (n = 13)
PD’:35.0%
Aminopenicillins, oral (n = 73, 29.9%);
aminopenicillins, injection (n = 44, 24.0%);
quinolone, oral (n = 30, 24.6%); quinolone,
injection (n = 13, 21.3%); cefalosporin, oral
(n = 14, 23.0%); cefalosporin, injection
(n = 10, 16.4%); macrolides, oral (n = 53,
29.0%); macrolides, injection (n = 29,
15.8%); tetracycline, oral (n = 19, 15.6%)




A. et al. (2015) [66] 100 PH 100.0%
Cefodoxime (n = 52), amoxicillin (n = 30),




(2014) [68] 54 Ph 100.0%
Amoxicillin, amoxicillin/clavulanic acid,
azithromycin
Sore throat, sinusitis (pregnant), UTI, ear
infection (child), and skin infection
Farah R et al.
(2014) [69] 100 Ph 32.0%
Gastrointestinal symptoms, Genito-urinary




152 PH 9.8% of the total number of antibioticsdispensed
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Table 3. Cont.
Authors (Year) Sample Size Frequency of AntibioticDispensation without a Prescription
Name/Class of Antibiotics Most Often
Dispensed without a Prescription
Types of Disease/Symptoms Most
Commonly Associated with
Dispensation without a Prescription
Sabry NA et al.
(2014) [71] 36 PH, 1158 INT
36.4%
Upon pharmacist’s recommendation:
13.1%, n = 152
Upon patient´s request: 23.3%,
n = 270
Upon pharmacist´s recommendation:
Amoxicillin/fluoxacillin (n = 10, 6.58%),
ampicillin/sulbactam (n = 10, 6.58%),
amoxicillin (n = 8, 5.26%), co-amoxiclav
(n = 11, 7.24%), cephalexin (n = 21, 13.82%),
cephradine (n = 10, 6.58%), cefaclor (n = 7,
4.61%), cefuroxime (n = 5, 3.29%),
cefoperazone (n = 8, 5.26%), cefotaxime
(n = 7, 4.61%), ceftriaxone (n = 7, 4.61%),
oxycycline (n = 7, 4.61%), tetracycline
(n = 3, 1.97%), clarithromycin (n = 4,
2.63%), clindamycin (n = 9, 5.92%),
co-trimoxazole (n = 5, 3.29%), ciprofluxacin
(n = 7, 4.61%), gatifluxacin (n = 8, 5.26%)
and moxifloxacin (n = 5, 3.29%).
Upon patient´s request:
Amoxicillin/fluoxacillin (n = 28, 10.37%),
co-amoxiclav (n = 24, 8.89%), amoxycillin
(n = 44, 16.30%), azatreonam (n = 4, 1.48%),
doxycycline (n = 20, 7.40%), tetracyclin
(n = 4, 1.48%), cephadrin (n = 13, 4.81%),
cephalexin (n = 3, 1.11%), cefadroxil
(n = 12, 4.44%), cefuraxime (n = 2, 0.74%),
cefixime (n = 10, 3.70%), cefotaxime (n = 4,
1.48), ceftriaxone (n = 4, 1.48), azithromycin
(n = 12, 4.44%), spiramycin (n = 8, 2.96%),
roxithromycin (n = 4, 1.48%), erythromycin
(n = 8, 2.96%), clindamycin (n = 8, 2.96%),
co-trimoxazole (n = 6, 2.22%), ciprofloxacin
(n = 6, 2.22%), sparfloxacin (n = 5, 1.85%),
moxifloxacin (n = 5, 1.85%), levofloxacin
(n = 8, 2.96%), ofloxacin (n = 8, 2.96%),
entamycin (n = 4, 1.48%), chloramphenicol
(n = 3, 1.11%), fusidic acid (n = 8, 2.96%),
neomycin/bacitracin (n = 5, 1.85%).
Upon pharmacist´s recommendation: UTI
(n = 25, 17.86%), sore throat (n = 24,
17.10%), cold & flu (n = 16, 11.40%),
toothache (n = 13, 9.29%), infected wound
(n = 11, 7.86%), rhinitis (n = 8, 5.70%), acne
(n = 8, 5.70%), abdominal cramps (n = 7,
5.00%), tonsillitis (n = 5, 3.57%), post nasal
discharges (n = 4, 2.90%), burning (n = 4,
2.90%), asthma (n = 4, 2.90%), food
poisoning (n = 4, 2.90%), stomachache
(n = 4, 2.90%) and fracture (n = 3, 2.14%).
Upon patient´s request: Fever (n = 36,
15.52%), sore throat (n = 25, 10.78%),
tonsillitis (n = 19, 8.19%), gingivitis (n = 16,
6.9%), UTI (n = 12, 5.17%), ear ache &
inflammation (n = 12, 5.17%), acne (n = 9,
3.88%), wound infection (n = 8, 3.45%),
toothache (n = 8, 3.45%), headache (n = 7,
3.02%), urticaria (n = 7, 3.02%), vomiting
(n = 6, 2.59%), food poison (n = 6, 2.59%),
otitis (n = 6, 2.59%), flu (n = 5, 2.16%),
vaginites (n = 5, 2.16%), sneezing (n = 4,
1.72%), sinusitis (n = 4, 1.72%), cough
(n = 4, 1.72%), difficulty in breathing (n = 4,
1.72%), skin infection (n = 4, 1.72%),
dandruff (n = 4, 1.72%), endometritis (n = 4,
1.72%), prostatitis (n = 4, 1.72%), dizziness
(n = 4, 1.72%), nones/joint infection (n = 4,
1.72%), abortion (n = 3, 1.29%),
and irritation (n = 2, 0.86%).
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Authors (Year) Sample Size Frequency of AntibioticDispensation without a Prescription
Name/Class of Antibiotics Most Often
Dispensed without a Prescription
Types of Disease/Symptoms Most
Commonly Associated with
Dispensation without a Prescription
Zapata-Cachafeiro
M. et al. (2014) [72] 286 Ph 64.7%, n = 185 Urinary and dental infections
Abasaeed AE et al.
(2013) [73] 20 Ph, 1645 INT 26.4%
Ceftriaxone (53.3%), amoxicillin (47.8%),
and co-amoxiclav (33.6%)
Cough, influenza, respiratory tract
infections, STD, and Helicobacter pylori
Rauber C. et al.
(2009) [84] 46 Ph 85.0%
Diseases: Throat infection, UTI, ear
infection, sinusitis, pharyngitis, upper
airway infection, pneumonia, fever, dental
infection, throat plaque, clear and simple
infection, skin infection, intestinal infection,
cough with secretion, oral infection,
and acne.
Symptoms: High fever, formation of throat
plaques, pus, pain, sore throat, sinusitis,
headache, edema, non-effective
anti-inflammatory, intense redness, severe
cramps, diarrhea, inflammation, symptoms
for more than seven days, and mucus.
Nyazema N et al.
(2007) [86] 59 PH, 73 PS PD: 31.0%
Amoxicillin (77%), cotrimoxazole (60%),
erythromycin (30%), doxycycline (48%)
Caamaño F et al.
(2005) [87] 123 PH, 164 Ph 65.9% Clamoxyl
® (Amoxicillin)
Caamano Isorna
F. et al. (2004) [89] 123 PH, 164 Ph 65.9% Clamoxyl
® (Amoxicillin)
Chalker J et al.
(2002) [91]
44 PH (22 control and
22 intervention)
51.0%
Intervention: 57.0%, n = 12.5 and
Control: 45.0%, n = 10
Cefalexin (Intervention: 57% and Control:
45%)
Simple URTI in a child < 5 years old with
a mild cough.
Sample size: PH, Pharmacies; Ph, Pharmacists; PS, Pharmacy Staff; INT, Interactions; Frequency of antibiotic dispensation without a prescription: PD: Percentage corresponding to
pharmacists who report dispensing antibiotics without a prescription calculated using the strategy: 100% less than the percentage of pharmacists who report never dispensing antibiotics
without a prescription; PSD: Percentage corresponding to pharmacists who report dispensing antibiotics without a prescription sometimes/occasionally.; PD´: Percentage corresponding to
pharmacists who report dispensing antibiotics without a prescription calculated using the strategy: 100% less than the percentage of pharmacists who report never/rarely dispensing
antibiotics without a prescription; Types of disease/symptoms most commonly associated with dispensation without a prescription: UTI, Urinary Tract Infection; URTI, Upper Respiratory
Tract Infection; STD, Sexually Transmitted Diseases. a Articles that do not explicitly mention throughout the full article that it is about dispensing antibiotics without a prescription, but
rather the management of diseases/symptoms in pharmacies/drugstores.
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Table 4. Questions and advice provided when dispensing antibiotics without a prescription.
Authors (Year) Questions Asked at the Time of Dispensation Advice Given at the Time of Dispensation
Simulated patient method
Al-Tannir M. et al. (2020) [17]
2011
In all scenarios presented (sore throat, acute sinusitis, otitis
media, acute bronchitis, diarrhea, and UTI), none of the
pharmacies asked about the drug allergy history
2011
In all scenarios presented (sore throat, acute sinusitis, otitis media,
acute bronchitis, diarrhea, and UTI), none of the pharmacies
provided information on potential drug–drug interactions
2018
Asked about history of drug allergies (n = 4, 9.8%)
2018
Provided information regarding potential drug-drug interactions
(n = 21, 51.2%)
Halboup A. et al. (2020) [30]
Sore throat
Asked whether the woman was pregnant (n = 31, 15.6%)
Cough
Asked whether the woman was pregnant (n = 20, 10.8%);
Asked about the type of cough (productive or dry) (n = 166,
83.0%).
Diarrhea
Asked whether the woman was pregnant (=11, 7.3%)
Otitis media
Asked whether the woman was pregnant (=3, 2.0%)
Sore throat
Explained how to use antibiotics (n = 172, 86.4%)
Educated the patient about treatment duration (n = 145, 72.9%)
Cough
Explained how to use antibiotics (n = 72, 39.1%)
Educated the patient about treatment duration (n = 12, 6.5%)
Diarrhea
Explained how to use antibiotics (n = 117, 75.9%)
Educated the patient about treatment duration (n = 78, 50.6%)
Otitis media
Explained how to use antibiotics (n = 98, 95.1%)
Educated the patient about treatment duration (n = 97, 95.1%)
UTI
Explained how to use antibiotics (n = 85, 88.5%)
Educated the patient about treatment duration (n = 90, 61.2%)
Alrasheedy AA. et al. (2019) [34] ______
Pharyngitis
Education and counseling about the importance of adherence and
appropriate use of antibiotics (50.0%)
UTI
Education and counseling about the importance of adherence and
appropriate use of antibiotics (52.0%)
Chang J. et al. (2019) [7]
Diarrhoea
Asked about drug allergy history (n = 188, 16.1%)
URTI
Asked about drug allergy history (n = 494, 29.2%)
Diarrhoea
Provided medication advice (n = 251, 21.5%)
URTI
Provided medication advice (n = 403, 23.8%)
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Damisie G et al. (2019) [35] ______
Sore throat
Explained how to take the antibiotics (n = 9, 64.3%)
Explained how to take the antibiotics and duration of treatment
(n = 1, 7.1%)
Explained instruction on side effects (n = 1, 7.1%)
Providing no counseling (n = 3, 21.4%)
Acute diarrhea
Explained how to take the antibiotics (n = 5, 31.2%)
Explained how to take the antibiotics and duration of treatment
(n = 4, 25.0%)
Explained instruction on side effects (n = 1, 6.2%)
Provided no counseling (n = 3, 18.7%)
UTI
Explained how to take the antibiotics (n = 15, 88.2%)
Explained instruction on side effects (n = 1, 5.9%)
Provided no counseling (n = 1, 5.9%)
Koji EM et al. (2019) [37]
Asked about drug allergy history (n = 19);
Asked whether a doctor’s visit had taken place (n = 104);
Asked about child’s symptoms (n = 70)
______
Mengistu G et al. (2019) [11] None of the pharmacists asked about medication history andnutrition condition
None of the pharmacists provided infomed information about side
effects and major interactions
Zawahir S et al. (2019) [38]
Further questioned about their symptoms or concurrent
medical conditions (n = 36, 36.0%)
Questions related to action that has already been taken
(n = 12, 12.0%)
Questions related to drug allergies (n = 10, 10.0%)
Questions related to concurrent medicines used (n = 2, 2.0%)
In 18.0% (n = 44) of the instances, pseudo patients were
recommended to see a physician, in about a quarter of them
(n = 11, 25.0%) an antibiotic was still provided
Explained how to take (n = 59, 60.0%)
Explained how often to take (n = 47, 47.0%)
Explained when to stop taking (n = 22, 22.0%)
Erku D.A. et al. (2018) [43]
Asked about drug allergies (n = 7, 8.1%)
Queries about past medical and medication history (n = 18,
20.9%)
Instruction on dose and duration (n = 36, 41.9%)
Instruction on side effects (n = 24, 27.9%)
Advice to visit physician (n = 9, 10.6%)
Non-pharmacological advice (n = 12, 14.0%)
Horumpende PG et al. (2018) [20] ______ None of the pharmacies/retailers voluntarily explained the possibleside effects
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Authors (Year) Questions Asked at the Time of Dispensation Advice Given at the Time of Dispensation
Chang J. et al. (2017) [52]
Paediatric diarrhoea
Asked further questions about the patient’s condition (n = 58,
40.6%)
Asked about drug allergies (=85, 59.4%)
Enquired about other symptoms (n = 6, 4.2%)
Asked whether the patient had taken other drugs (n = 3, 2.1%)
Adult acute URTI
Further enquired regarding patient’s condition (n = 160,
80.4%)
Asked whether had other symptoms or not (n = 64, 32.2%)
Asked whether had taken other drugs or not (n = 13, 6.5%)
Asked about the drug allergy history (n = 82, 41.2%)
Paediatric diarrhoea
Provided medication advice (n = 25, 17.5%)
Adult acute URTI
Provided medication advice (n = 19, 9.6%)
Marković-Peković V et al. (2017) [18]
2010
Patient information given (Written) (n = 59, 77.6%)
Patient information given (Oral) (n = 72, 94.7%)
Patient information given (Both) (n = 57, 75.0%)
Patient information given (None) (n = 2, 2.6%)
Asked about penicillin allergy (n = 59, 77.6%)
Asked about taking other medicines (n = 19, 25.0%)
______
2015
Patient information given (Written) (n = 36, 50.7%)
Patient information given (Oral) (n = 46, 64.8%)
Patient information given (Both) (n = 32, 45.1%)
Patient information given (None) (n = 21, 29.6%)
Asked about penicillin allergy (n = 45, 64.3%)
Asked about taking other medicines (n = 16, 22.5%)
______
Okuyan B. et al. (2017) [54] None of the pharmacists asked about drug allergies
None of the pharmacists provided any information about other
medications that could be used if an unusual condition occurred or
if the patient forgot to take the medication
Guinovart MC et al. (2016) [57]
In 88 cases (73.9%) the patient was not asked about
background of allergies to any antibiotics
In none of the cases was the patient asked if she was pregnant
Asked whether the patient was taking contraceptive
treatment (n = 2, 1.7%)
Advice to visit a physician (36.1%)
Explained the duration and treatment (n = 114, 95.8%)
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Almaaytah A et al. (2015) [62] Asked about drug allergy (n = 26, 17.3%)Asked about the concomitant use of other drugs (n = 8, 5.3%)
Explained how to take the antibiotic (n = 143, 95.3%)
Explained the duration of treatment (n = 25, 16.7%)
Recommended consulting a physician (n = 6, 4.0%)
Shet A et al. (2015) [65] None of the pharmacists asked about drug allergies
None of the pharmacies provided counseling on expected side
effects
Instructions regarding the dose of the antimicrobial drugs (n = 101,
58.0%)
Instructions regarding the duration of the antimicrobial drugs
(n = 89, 51.1%)
Alabid A.H.M.A. et al. (2014) [67]
Asked “What symptoms have you got?” (n = 29)
Asked “How long have you had the symptoms?” (n = 21)
Concerning soliciting information about the colour of sputum
(n = 11 (23.9%)
Asked “Is there any blood in sputum?” (n = 2)
Asked “How many times/year you presented the same
complaint?” (n = 1)
What medicines have you used before for? (n = 4)
Concerning soliciting information about allergies to
medicines (n = 14)
______
Marković-Peković V et al. (2012) [74] ______ Instructions for use given to the patients were oral (95%), written(78%), both (75.0%), and none (3.0%)
Rathnakar U.P. et al. (2012) [75] None of the pharmacists asked about drug allergies
Frequency advised without asking (n = 18)
Frequency advised after asking (n = 13)
Duration advised without asking (n = 19)
Duration advised after asking (n = 12)
Simó S et al. (2012) [76] None of the pharmacies asked about drug allergies None of the pharmacies explained the adverse effects
Puspitasari HP et al. (2011) [79]
In all the scenarios presented (product request for
ciprofloxacin 10 tablets 500 mg; product request for 2
capsules tetracycline 250 mg and amoxicillin dry syrups 125
mg per 5 mL), none of the respondents asked about allergies
In 2 of 3 scenarios (product request for ciprofloxacin 10
tablets 500 mg and product request for 2 capsules tetracycline
250 mg), none of the respondents asked about other
medications taken by the patient
In the scenarios (product request for ciprofloxacin 10 tablets 500
mg and amoxicillin dry syrups 125 mg per 5 mL), none of the
pharmacists informed about side effects,
precautions/interactions/contra-indications and the risks of the
medicine if not taken
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Hadi U et al. (2010) [80] The patients were never questioned or referred to a physician ______
Plachouras D et al. (2010) [82] No comment was made by the pharmacist and no reason forthe intended antibiotic use was requested (n = 107, 85.0%)
In the Amoxicillin + clavulanic acid case: n = 3 (4.2%) cases of
dispensing, the collaborator was informed by the pharmacist about
adverse events or asked whether such events had occurred in the
past when the buyer had used antibiotics
Llor C et al. (2009) [83]
Asked patient about other symptoms (n = 61, 68.5%)
Asked about drug allergies (n = 15, 16.9%)
Asked patient whether she might be pregnant (this question
was only necessary in the cases of UTI because the other
clinical cases were presented by men) (n = 2, 3.6%)
Explained how often to take the antibiotic (n = 74, 83.1%)
Explained how long the antibiotic should be taken (n = 62, 69.7%)
Recommended that patient should see a physician if there was not
any improvement (n = 4, 4.5%)
Wachter DA et al. (1999) [93]
In both scenarios, none of the pharmacies asked about drug
allergies




Hallit S et al. (2019) [36] Age (80.1%)Weight (80.7%)
Instructed the parents to shake the bottle before each
administration (81.2%)
Dilute the antibiotic to the indicated line (37.1%)
Store the antibiotic in the refrigerator (64.4%)
Give the exact dose (53.0%)
Administer it on time (46.5%) and for a defined duration of
treatment (47.5%)
Do not stop the antibiotic before consulting a physician or
pharmacist (32.2%)
Kalungia AC et al. (2016) [58] Asked the indication for using the specific antibioticrequested (94.0%)
Counselled on dosage instructions (n = 70, 95.9%)
Counselled on common side effects (n = 22, 30.1%)
No advice (n = 3, 4.1%)
Were involved in suggesting changes to the antibiotic choice or
brand (97.0%)
Bahnassi A. (2015) [63] Asking for the antibiotic indication (36.0%) No counseling (66.0%)Dosing directions (34.0%)
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Table 4. Cont.
Authors (Year) Questions Asked at the Time of Dispensation Advice Given at the Time of Dispensation
Bahnassi A. (2014) [68] Provided an antibiotic without asking for the indication(36.0%)
Finish the antibiotic even when symptoms are relieved (28.0%)
Discussed interactions with other medications (32.0%)
Discussed possible adverse reactions (58.0%)
Discussed dose and dosing regimens (82.0%)
Gastelurrutia M.A. et al. (2014) [70] ______ Just dispensed (56.9%)The doctor referred (12.1%)
Sabry NA et al. (2014) [71]
Upon pharmacist´s recommendation:
None of the pharmacies asked about drug allergies
Upon patient´s request:
None of the pharmacies asked about drug allergies
Upon pharmacist´s recommendation:
The pharmacist provided advice and usage instructions to 124
patients (77.5%)
Upon the patient´s request:
The dispensing pharmacist advised the patient to see the doctor
(n = 8)
UTI, Urinary Tract Infection; URTI, Upper Respiratory Tract Infection.
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Table 5. Comparison of the frequency of antibiotic dispensation without a prescription between the
two methods.
Country Simulated Patient Method Pharmacy Interview/Questionnaire Method
Saudi Arabia
Al-Tannir M. et al. (2020) [17]: [2011: 77.6%;
2018: 12.5%]
Alrasheedy AA. et al. (2019) [34]: 92.2%
Al-Mohamadi A et al. (2011) [78]: 97.9%
Al-Ghamdi MS. (2001) [92]: 82.0%
Alrasheedy AA. et al. (2019) [34]: 70.7%
Alhomoud F et al. (2018) [41]: 100.0%
Bahnassi A. (2014) [68]: 100.0%
Yemen Halboup A. et al. (2020) [30]: 73.3% Abood EA et al. (2016) [55]: 25.3%
Egypt Abdelaziz AI et al. (2019) [33]: 98.4% Sabry NA et al. (2014) [71]: 18.2%
Ethiopia
Damisie G et al. (2019) [35]: 94.4%
Koji EM et al. (2019) [37]: 63.4%
Mengistu G et al. (2019) [11]: 86.7%
Erku D.A. et al. (2018) [43]: 86.0%
Abegaz T.M. et al. (2016) [14]: 51.3%
Mengistu G et al. (2019) [11]: 50.5%
Erku D.A. (2016) [56]: 90.2%
India
Nafade V. et al. (2019) [19]: 4.0%
Satyanarayana S. et al. (2016) [61]: 27.0%
Shet A et al. (2015) [65]: 66.7%
Rathnakar U.P. et al. (2012) [75]: 51.7%
Barker A.K. et al. (2017) [51]: 100.0%
Shreya Svitlana A. et al. (2015) [66]: 100.0%
Sri Lanka
Zawahir S et al. (2019) [38]: 41.0%
Zawahir S et al. (2018) [49]: 61.0%
Wolffers I. (1987) [94]: 100.0%
Zawahir S. et al. (2019) [39]: 31.7%
Indonesia Puspitasari HP et al. (2011) [79]: 91.0%Hadi U et al. (2010) [80]: 75.9% Ajie A.A.D. et al. (2018) [40]: 92.1%
Pakistan Malik M. et al. (2013) [15]: 28.57%
Rehman IU et al. (2018) [46]: 68.0%
Sarwar M.R. et al. (2018) [47]: 93.7%
Nawab A. et al. (2016) [60]: 12.2%
Spain
Zapata-Cachafeiro M et al. (2018) [48]: 18.8%
Guinovart MC et al. (2016) [57]: 54.1%
Simó S et al. (2012) [76]: 8.0%
Llor C et al. (2010) [81]: 45.2%
Llor C et al. (2009) [83]: 45.2%
Gastelurrutia M.A. et al. (2014) [70]: 9.8%
Zapata-Cachafeiro M. et al. (2014) [72]: 64.7%
Caamaño F et al. (2005) [87]: 65.9%
Caamano Isorna F. et al. (2004) [89]: 65.9%
Nepal Wachter DA et al. (1999) [93]: 67.5% Ansari M. (2017) [50]: 66.5%
Syria Al-Faham Z et al. (2011) [77]: 97.0% Mansour O. et al. (2017) [53]: 85.5%Bahnassi A. (2015) [63]: 100.0%
Malaysia Alabid A.H.M.A. et al. (2014) [67]: 32.0% Khan M.U. et al. (2016) [59]: 63.3%
Brazil Volpato DE et al. (2005) [88]: 74.0% Rauber C. et al. (2009) [84]: 85.0%
Vietnam Chalker J et al. (2000) [16]: 81.5% Chalker J et al. (2002) [91]: 51.0%
Zimbabwe Nyazema N et al. (2007) [86]: 8.0% Nyazema N et al. (2007) [86]: 31.0%
3. Discussion
The dispensing of antibiotics without a prescription remains a common practice worldwide,
especially in low- and middle-income countries, and the community pharmacies/drugstores continue
to be a major source of antibiotic acquisition without a medical prescription [95,96]. With this is mind,
there is an urgent need to improve prescription practices in low- and middle-income countries, starting
from the integration of treatment recommendations into their national guidelines, and reinforcement
of the awareness of this public health problem, togeher with their possible consequences to humanity.
In high income countries this is a less common practice as several factors may affect prescribing
behaviors, such as socio-cultural context, financial incentives, personal beliefs, patients’ attitudes
and greater awareness of the antibiotic resistance problem due to an easier information access when
compared to low- and middle-income countries [97,98]. The development of educational strategies in
high-income countries has proven to be not enough, since the sale of antibiotics without prescription
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continues to emerge. So, there is a need to intensify these strategies, through the involvement of all
stakeholders, with more advertising campaigns, more workshops, and more publicity. Likewise, law
enforcement to reduce non-prescription sales of antibiotics with significant penalties and revocation of
professional licenses in case of non-compliance also seems to be a good strategy to be adopted [99,100].
To the best of our knowledge, this is the first study that compares the frequency of dispensing
antibiotics without a prescription by using two different data collection methods. Most of the studies
included in this review used the simulated patient method. This may be related to the fact that
the interview/questionnaire method implies greater participation and proximity to the pharmacy
professional, with the lack of anonymity potentially leading to less honest answers. On the other hand,
the simulated patient is an effective data collection method which provides internal validity [101].
The analysis of the results obtained in the systematic review, reveal that the values for this practice
remain high, reaching 100% in some of the studies. Since the average value of the percentage of antibiotic
dispensation without a prescription in the simulated patient method is very similar to the percentage
found through the method with interviews/questionnaires, it seems that the Hawthorne effect did
not have much impact in the studies using the first method. Furthermore, in the simulated patient
method, most antibiotics were easily dispensed at low insistence levels by patients. A study conducted
in 2018 in European and Anglo-Saxon countries showed that, although the consumption of antibiotics
is decreasing, patients still see antibiotics as available products that can be easily bought [102].
Results of this study highlight that the highest percentages of antibiotic dispensation without
a prescription occurred in Asia. The overuse of antibiotics is an evident concern in this part of the
world, with these drugs being often available for sale without a prescription [103]. A large number of
studies analyzed in this review took place in Asia (51 articles representing 60% of the total), which
may influence the fact that they also display the highest percentage of antibiotics dispensed without
prescription, since they stand out more in relation to studies carried out in other parts of the world.
Our results reveal that there were few studies in Anglo Saxon countries. Thus, we alert researchers to
develop studies in these countries.
Another important aspect to highlight is that in some of the articles it was possible to observe
a decrease in the frequency of dispensing antibiotics without a prescription, which led us to think that
the growing approach taken worldwide on this public health problem is beginning to have an impact
on the practices of health professionals.
The most commonly non-prescribed antibiotics sold identified in our review were amoxicillin
(53 articles), azithromycin (24 articles), ciprofloxacin (24 articles), and amoxicillin-clavulanic acid
(24 articles). These findings are in agreement with results found in a previous study that identified as
antibiotics mostly used for self-medication the penicillins, macrolides, cephalosporins, fluoroquinolones,
and tetracycline [96]. These specific classes of drugs have been associated for some time with increased
development of resistance to microorganisms such as Streptococcus pneumoniae, Acinetobacter
baumannii, Campylobacter jejuni, Enterococcus faecalis, and many others [104].
The pathologies/symptoms most commonly associated with dispensing antibiotics without
a prescription were respiratory system problems like sore throat, URTI, common cold, bronchitis,
cough, cold and flu, diarrhea, and UTI. Previously, another study concluded that the main pathologies
associated with the consumption of antibiotics without a prescription were sore throat, fever,
and respiratory problems, such as cold/flu and cough [96]. Patients should be educated and encouraged
by pharmacists to go to primary health care units whenever they have these minor illnesses.
A systematic review recently carried out identified the main intrinsic factors that influence the
dispensing of antibiotics without a prescription, such as the low level of training of professionals
working in pharmacies, as well as their attitudes such as complacency, ignorance, responsibility,
indifference, and economic benefit [105]. In our study, concerning questions and advice provided by
pharmacists at the time of dispensing antibiotics without a prescription showed very low percentages,
with the advice being absent a few times. When this occurred, the information primarly provided
corresponded to explanations about how to use antibiotics and the duration of treatment. Pharmacy
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professionals have an essential role in dispensing antibiotics, so interventions must be implemented
with them. Most community pharmacists are aware that the irrational use of antibiotics is one of the
main causes of increased antibiotic resistance and that all healthcare professionals, including themselves,
need to think rationally and stop prescribing and dispensing so many antibiotics inadequately [95].
However, a previous study has found that the implementation of multiple activities among pharmacists,
like national campaigns and programs, workshops for health professionals, creation of posters and
flyers, television programs, newspapers and lauch of guidelines for counseling patients, improved
antibiotic use and consequently reduced inappropriate antibiotic prescription and dispensation [18].
We can see that there are discrepancies between knowledge and practice.
One strengh of this review is the heterogeneous composition of the included studies that were
analyzed, which increased the generalization of the results and, consequently, the external validation
of this review.
A limitation of our study is that it does not take into account any intervention implemented to
decrease the dispensation of antibiotics without a prescription in the countries, after the studies were
carried out. Another limitation of this review concerns with the lack of inclusion of studies concerning
veterinary use. A large portion of all antibiotic use is for veterinary use. Additionally, an increase in
global consumption is expected to occur in livestock between 2010 and 2030, thus leading to a rise in
the incidence of bacteria resistant to antimicrobials in animals, with a possible high transmission to
humans [106,107].
4. Materials and Methods
4.1. Search Strategy/Search Methods for Identification of Studies
This systematic review followed the PRISMA (Preferred Reporting Items for Systematic Reviews
and Meta-Analyses) guidelines, which is a template developed to help authors improving the reporting
of systematic reviews and meta-analyses [108], and was registered in the PROSPERO network
(registration number: CRD42020189331).
The databases MEDLINE Pubmed and Embase were searched in June 2020 using the
query: “(antibiotic OR antibiotics OR antimicrobial OR antimicrobials) AND (over-the-counter
OR nonprescription OR without-prescription OR self-medication) AND (community-pharmacy
OR community-pharmacies OR pharmacy OR pharmacies OR pharmacist OR pharmacists OR
community-pharmacist OR community-pharmacists)”, to identify studies that reported the dispensing
of non-prescribed antibiotics in community pharmacies and drugstores that sell drugs for human use.
4.2. Study Inclusion Criteria
Studies were considered eligible for this review if they met the following criteria: (i) studies
published in English, Portuguese, or Spanish; (ii) the study population was defined as pharmacies
or drugstores that sell drugs for human use; (iii) studies whose data collection method consists of
the simulated patient method and/or questionnaires/interviews with pharmacies; (iv) studies with
original/primary data, namely observational studies, and interventional studies since they present
pre-intervention/baseline data and (v) data referring to antibiotics for systemic use. Population-based
studies that explored public opinion and attitudes on the sources and use of non-prescription
antibiotics were excluded, as well as qualitative studies that did not present quantitative measures
of non-prescription supply of antibiotics. Studies focused on the administration of antiretroviral,
antimalarial, antifungal, and antiparasitic drugs were also excluded.
In articles addressing other target populations, only data referring to studies carried out in
pharmacies and with pharmacy workers were extracted.
All articles extracted were independently reviewed by two authors, who decided whether or not
these met the selection criteria. In case of disagreement, the paper in question was examined by a third
and fourth reviewer who took the final decision.
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4.3. Quality Assessment
All selected studies were assessed for quality and risk of bias through the Appraisal tool for
Cross-Sectional Studies (AXIS). This tool consists of a 20 items questionnaire that addressed study
quality and reporting, assessing whether the published conclusions are reliable and credible about the
objective, methods, and results [109]. For each study, the risk of bias and quality was conducted by
two researchers and, in case of disagreement, a third reviewer acted as a referee to reach a consensus.
4.4. Data Extraction
To summarise the general characteristics of the studies selected in the previous analysis, Table 1
was drawn up showing the following parameters: author (year of publication), study location/country,
study design, and data collection method.
Additionally, to indicate the extent of antibiotic dispensation without a prescription and additional
outcomes, two tables were created, one referring to the simulated patient method and the other
referring to the interview/questionnaire method in pharmacies. The table related to the simulated
patient method (Table 2) presents the following parameters: sample size, frequency/prevalence of
antibiotic dispensing without a prescription, name/class of antibiotics most dispensed, types of
diseases/symptoms most commonly associated with dispensing without a prescription and level of
insistence by simulated patients.
Regarding the outcome “level of insistence by simulated patients”, the levels of insistence recorded
are those defined by the authors of each study. These have been recorded in Table 2, specifically in the
associated column, before the percentage for each level of insistence is presented. Regardless of the
divergence in the definition of the levels by the various authors, the common issue between them is
that the lower level is associated with a lower level of insistence by the simulated patient of generally
only asking for medication for symptom relief. As the level increases, the simulated patients start
asking for stronger medication and even specifically for antibiotics.
The pharmacy interview/questionnaire method table (Table 3) shows the following outcomes:
sample size, frequency/prevalence of antibiotic dispensation without a prescription, name/class of
antibiotics most often dispensed and types of diseases/symptoms most commonly associated with
dispensation without a prescription.
Another table (Table 4) was constructed to record the addressed questions, the advice
given at the time of antibiotics dispensing without a prescription, as well as the percentage of
pharmacies/pharmacists who performed them.
Subsequently, data on the comparison of the frequency of dispensing antibiotics without
a prescription between the two methods were extracted and introduced in Table 5.
Data were extracted by two reviewers and any discrepancy was resolved by a third and fourth reviewer.
5. Conclusions
The dispensing of antibiotics without prescription is one of the major drivers of antibacterial
resistance. Our results suggest that this practice is still common in many countries, especially in
low- and middle-income countries. Pharmacies and their work professionals play a critical role
in the conservation of effective antibiotics, through denying the dispensing of antibiotics without
a prescription and improving patient pharmaceutical counseling, overall in respiratory and UTI and in
diarrhea. It becomes urgent to empower these health professionals, especially in developing countries,
through the implementation of educational and/or administrative strategies in order to reduce the
dispensation of antibiotics without a prescription.
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